Agaricus blazei extract attenuates rotenone-induced apoptosis through its mitochondrial protective and antioxidant properties in SH-SY5Y neuroblastoma cells

References

• Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2005;68:384–6. doi: 10.1212/01.wnl.0000247740.47667.03
   Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197–211. doi: 10.1016/S0197-4580(02)00065-9
   PubMed Web of Science ®Google Scholar
• Janakiraman U, Manivasagam T, Justin Thenmozhi A, Essa MM, Barathidasan R, Saravana Babu C, et al. Influences of chronic mild stress exposure on motor, non-motor impairments and neurochemical variables in specific brain areas of MPTP/probenecid induced neurotoxicity in mice. PLoS One 2016;11:e0146671. doi: 10.1371/journal.pone.0146671
   PubMed Web of Science ®Google Scholar
• Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, et al. The movement disorder society evidence based medicine review update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011;26:S2–41. doi: 10.1002/mds.23829
   PubMed Web of Science ®Google Scholar
• Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, et al. The movement disorder society evidence based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011;26:S42–80. doi: 10.1002/mds.23884
   PubMed Web of Science ®Google Scholar
• Beal MF. Experimental models of Parkinson's disease. Nat Rev Neurosci 2001;2:325–32. doi: 10.1038/35072550
   PubMed Web of Science ®Google Scholar
• Dawson TM. New animal models for Parkinson's disease. Cell 2000;101:115–8. doi: 10.1016/S0092-8674(00)80629-7
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson's disease. Bio Essays 2002;24:308–18.
   PubMed Web of Science ®Google Scholar
• Joshi S, Guleria R, Pan J, DiPette D, Singh US. Retinoic acid receptors and tissue-transglutaminase mediate short-term affect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene 2006;25:240–7. doi: 10.1038/sj.onc.1209027
   PubMed Web of Science ®Google Scholar
• Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crests lineages. Cancer Res 1989;49:219–25.
   PubMed Web of Science ®Google Scholar
• Kavitha M, Manivasagam T, Essa MM, Tamilselvam K, Selvakumar GP, Karthikeyan S, et al. Mangiferin antagonizes rotenone: induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells. Neurochem Res 2014;39:668–76. doi: 10.1007/s11064-014-1249-7
   PubMed Web of Science ®Google Scholar
• Tamilselvam K, Braidy N, Manivasagam T, Essa MM, Prasad NR, Karthikeyan S, et al. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxid Med Cell Longev 2013;2013:102741. doi: 10.1155/2013/102741
   PubMed Web of Science ®Google Scholar
• Hensley K, Pye QN, Maidt ML, Stewart CA, Robinson KA, Jaffrey F, et al. Interaction of-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J Neurochem 1998;71:2549–57. doi: 10.1046/j.1471-4159.1998.71062549.x
   PubMed Web of Science ®Google Scholar
• Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 1998;13:24–34.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Park HJ, Park HK, Chung JH. Tranexamic acid protects against rotenone induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology 2009;262:171–4. doi: 10.1016/j.tox.2009.06.004
   PubMed Web of Science ®Google Scholar
• Dhanalakshmi C, Manivasagam T, Nataraj J, Justin Thenmozhi A, Essa MM. Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells. Evid Based Complement Alternat Med. 2015;2015:626028. doi: 10.1155/2015/626028
   PubMed Web of Science ®Google Scholar
• Peralta RM, De Oliveira AL, Eler GJ, Soares AA, Bracht A. Functional properties of edible and medicinal mushrooms. Curr Trends Microbiol 2008;4:45–60.
   Google Scholar
• Ferreira IC, Barros L, Abreu RM. Antioxidants in wild mushrooms. Curr Med Chem 2009;16:1543–60. doi: 10.2174/092986709787909587
   PubMed Web of Science ®Google Scholar
• Ramkumar V, Nie Z, Rybak LP, Maggirwar SB. Adenosine, antioxidant enzymes and cytoprotection. Trends Pharmacol Sci 1995;16:283–5. doi: 10.1016/S0165-6147(00)89051-3
   PubMed Web of Science ®Google Scholar
• Nie Z, Mei Y, Ford M, Rybak L, Marcuzzi A, Ren H, et al. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor κB. Mol Pharmacol. 1995;53:663–9.
   Google Scholar
• Greenwood B. Review: intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 2006;11:983–91. doi: 10.1111/j.1365-3156.2006.01657.x
   PubMed Web of Science ®Google Scholar
• Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49–59. doi: 10.1016/j.eururo.2009.07.049
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AC, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1995;193:265–75.
   Google Scholar
• Hissin PJ, Hilf RA. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214–26. doi: 10.1016/0003-2697(76)90326-2
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192–205. doi: 10.1016/0003-2697(68)90092-4
   PubMed Web of Science ®Google Scholar
• Soares AA, de Oliveira AL, Sá-Nakanishi AB, Comar JF, Rampazzo AP, Vicentini, FA, et al. Effect of an Agaricus blazei aqueous extract pretreatment on paracetamol induced brain and liver injury in rats. Biomed Res Int 2013;2013:469180.
   PubMedGoogle Scholar
• de Sá-Nakanishi AB, Soares AA, de Oliveira AL, Comar JF, Peralta RM, Bracht A. Effects of treating old rats with an aqueous Agaricus blazei extract on oxidative and functional parameters of the brain tissue and brain mitochondria. Oxid Med Cell Longev 2014;2014:563179. doi: 10.1155/2014/563179
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Jayaraj RL, Tamilselvam K, Manivasagam T, Elangovan N. Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson's disease. J Mol Neurosci 2013;51:863–70. doi: 10.1007/s12031-013-0075-8
   PubMed Web of Science ®Google Scholar
• Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005;5:12. doi: 10.1186/1472-6750-5-12
   PubMed Web of Science ®Google Scholar
• Niehaus WG Jr, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968;6:126–30. doi: 10.1111/j.1432-1033.1968.tb00428.x
   PubMedGoogle Scholar
• Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130–2.
   PubMed Web of Science ®Google Scholar
• Aebi HE. Catalase. In: Bergmeyer HU, (ed.) Methods of enzymatic analysis. Weinheim: Verlag Chemie; 1983. p. 273–86.
   Google Scholar
• Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588–90. doi: 10.1126/science.179.4073.588
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–77. doi: 10.1016/0003-9861(59)90090-6
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna A, Panov V, Greemamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's diseases. Nat Neurosci 2000;3:1301–6. doi: 10.1038/81834
   PubMed Web of Science ®Google Scholar
• Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophy 1985;237:408–14. doi: 10.1016/0003-9861(85)90293-0
   PubMed Web of Science ®Google Scholar
• Perier C, Tieu C, Guégan C, Caspersen C, Jackson-Lewis V, Carelli V, et al. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci USA 2005;102:19126–31. doi: 10.1073/pnas.0508215102
   PubMed Web of Science ®Google Scholar
• Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson's disease. IUBMB Life 2001;52:135–41. doi: 10.1080/15216540152845939
   PubMed Web of Science ®Google Scholar
• Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 2002;278:8516–25. doi: 10.1074/jbc.M210432200
   PubMed Web of Science ®Google Scholar
• Sipos I, Tretter L, Adam-Vizi V. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals. J Neurochem 2003;84:112–8. doi: 10.1046/j.1471-4159.2003.01513.x
   PubMed Web of Science ®Google Scholar
• Seaton TA, Cooper JM, Schapira AH. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997;777:110–8. doi: 10.1016/S0006-8993(97)01034-2
   PubMed Web of Science ®Google Scholar
• Carneiro AAJ, Ferreira ICFR, Dueñas M, Barros L, da Silva R, Gomes E, et al. Chemical composition and antioxidant activity of dried powder formulations of Agaricus blazei and Lentinus edodes. Food Chem 2013;138:2168–73. doi: 10.1016/j.foodchem.2012.12.036
   PubMed Web of Science ®Google Scholar
• Hakime-Silva RA, Vellosa JC, Khalil NM, Khalil OA, Brunetti IL, Oliveira OM. Chemical, enzymatic and cellular antioxidant activity studies of Agaricus blazei Murrill. An Acad Bras Cienc 2013;85:1073–81. doi: 10.1590/S0001-37652013005000044
   PubMed Web of Science ®Google Scholar
• Brown GC, Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Bio Med 2002;33:1440–50. doi: 10.1016/S0891-5849(02)01112-7
   PubMed Web of Science ®Google Scholar
• Ebadi M, Sharma SK. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Sign 2003;5:319–35. doi: 10.1089/152308603322110896
   PubMed Web of Science ®Google Scholar
• Molina-Jiménez MF, Śanchez-Reus MI, Andres D, Cascales M, Benedi J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res 2004;1009:9–16. doi: 10.1016/j.brainres.2004.02.065
   PubMed Web of Science ®Google Scholar
• Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1997;1362:77–86. doi: 10.1016/S0925-4439(97)00070-7
   PubMed Web of Science ®Google Scholar
• de Sá-Nakanishi AB, Soares AA, Natali MRM, Comar JF, Peralta RM, Bracht A. Effects of the continuous administration of an Agaricus blazei extract to rats on oxidative parameters of the brain and liver during aging. Molecules 2014b;19:18590–603. doi:10.3390/molecules191118590
   PubMed Web of Science ®Google Scholar
• Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988;4:155–81. doi: 10.1146/annurev.cb.04.110188.001103
   PubMedGoogle Scholar
• Rahn CA, Bombick DW, Doolittle DJ. Assessment of mitochondrial membrane potential as an indicator of cytotoxicity. Fundam Appl Toxicol 1991;16:435–48. doi: 10.1016/0272-0590(91)90084-H
   PubMedGoogle Scholar
• Ubl JJ, Chatton JY, Chen S, Stucki JW. A critical evaluation of in situ measurement of mitochondrial electrical potentials in single hepatocytes. Biochem Biophys Acta 1996;1276:124–32.
   PubMed Web of Science ®Google Scholar
• Batandier C, Leverve X, Fontaine E. Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Bio Chem 2004;279:17197–204. doi: 10.1074/jbc.M310329200
   PubMed Web of Science ®Google Scholar
• Franco R, Sánchez-Olea R, Reyes-Reyes EM, Panayiotidis MI. Environmental toxicity, oxidative stress and apoptosis: Ménage à trois. Mutat Res 2009;674:3–22. doi: 10.1016/j.mrgentox.2008.11.012
   PubMed Web of Science ®Google Scholar
• Ullah N, Ullah I, Lee HY, Naseer MI, Seok PM, Ahmed J, et al. Protective function of nicotinamide against ketamine induced apoptotic neurodegeneration in the infant rat brain. J Mol Neurosci 2012;47:67–75. doi: 10.1007/s12031-011-9685-1
   PubMed Web of Science ®Google Scholar
• Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000;256:50–57. doi: 10.1006/excr.2000.4839
   PubMed Web of Science ®Google Scholar
• Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci 2007;120:1707–16. doi: 10.1242/jcs.03443
   PubMed Web of Science ®Google Scholar
• Parker WD Jr, Swerdlow RH. Mitochondrial dysfunction in idiopathic Parkinson's disease. Am J Hum Genet 1998;62:758–62. doi: 10.1086/301812
   PubMed Web of Science ®Google Scholar
• Kwon IH, Choi HS, Shin KS, Lee BK, Lee CK, Hwang BY, et al. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease. Neurosci Lett 2010;486:29–33. doi: 10.1016/j.neulet.2010.09.038
   PubMed Web of Science ®Google Scholar